Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Qizhen Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8523-3468; OpenAlex author ID A5004948938. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Multiparametric MRI to Predict Response to Irreversible Electroporation Plus Anti-PD-1 Immunotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mrm.70188↗
  2. The abscopal effect of IRE combined with anti–PD-1 achieves local ablation and systemic control of PDAC Co-author DOI 10.64898/2026.05.04.722535↗
  3. Re/99mTc Tricarbonyl Phenformin Complexes Targeting Mitochondria as Pancreatic Cancer Theranostics. Co-author DOI 10.1021/acs.jmedchem.5c01760↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chun Li · 2 shared papers, 2025–2026 · strength 0.53
  2. Marty D. Pagel · 1 shared paper, 2026 · strength 0.29
  3. Sanaz Javadi · 1 shared paper, 2026 · strength 0.29
  4. Chun Li · 1 shared paper, 2026 · strength 0.25
  5. Chiyi Xiong · 1 shared paper, 2025 · strength 0.24
  6. Huamin Wang · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.